You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 17, 2025

Bulk Pharmaceutical API Sources for FLUONID


✉ Email this page to a colleague

« Back to Dashboard


Bulk Pharmaceutical API Sources for FLUONID

Vendor Vendor Homepage Vendor Sku API Url
TCI (Tokyo Chemical Industry) ⤷  Get Started Free F0657 ⤷  Get Started Free
Molport ⤷  Get Started Free MolPort-002-528-328 ⤷  Get Started Free
Hangzhou APIChem Technology ⤷  Get Started Free AC-429 ⤷  Get Started Free
AKos Consulting & Solutions ⤷  Get Started Free AKOS015963144 ⤷  Get Started Free
Finetech Industry Limited ⤷  Get Started Free FT-0631295 ⤷  Get Started Free
>Vendor >Vendor Homepage >Vendor Sku >API Url

Bulk Active Pharmaceutical Ingredient (API) Sources for Fluonid

Last updated: July 29, 2025

Introduction

Fluonid, traditionally known as a fluoride-based pharmaceutical agent, is employed primarily in dental health formulations to prevent and reduce dental caries. As a key active pharmaceutical ingredient (API), its sourcing is critical for manufacturers aiming to uphold quality, regulatory compliance, and cost-effectiveness. The global landscape for bulk API sourcing involves a mix of established chemical manufacturers, contract manufacturing organizations (CMOs), and regional suppliers, each offering different advantages in terms of regulatory standards, pricing, and supply chain stability.

This article examines the primary sources of bulk Fluonid API, emphasizing reputable suppliers, geographic regions, and the emerging trends shaping the supply chain. It serves as an essential resource for pharmaceutical companies, formulators, and procurement specialists aiming to optimize their supply strategies for Fluonid.


Market Overview and Regulatory Context

Fluonid APIs are synthesized via complex chemical processes with high purity requirements, governed by stringent regulatory standards such as the United States Pharmacopeia (USP), European Pharmacopoeia (EP), and other regional authorities. Manufacturers must ensure compliance with Good Manufacturing Practices (GMP) to meet quality and safety standards, which influence API sourcing decisions.

The global demand for fluoride-based APIs has increased over recent years, driven by heightened awareness of dental health and expanding markets in emerging economies. The supply chain must be resilient to geopolitical shifts, manufacturing bottlenecks, and regulatory changes.


Key Global API Suppliers for Fluonid

1. Major Chemical Manufacturers in China

China remains a dominant force in fluoride chemical manufacturing — notably in sodium fluoride, stannous fluoride, and other fluoride compounds used as APIs.

  • Hubei Yitang Pharmaceutical Co., Ltd.
    Specializes in fluoride chemicals, including pharmaceutical-grade sodium fluoride. The company supplies bulk fluoride APIs compliant with international standards, offering cost advantages and scalable manufacturing.

  • Shandong Dawn Chemical Co., Ltd.
    An established producer of fluoride chemicals with GMP certification. The company’s fluoride APIs are widely used in dental formulations worldwide.

  • Jiangsu Yabang Chemical Co., Ltd.
    Known for high-purity fluoride salts with rigorous quality control processes aligned with GMP and pharmacopoeial standards.

2. Indian API and Specialty Chemical Producers

India’s pharmaceutical industry emphasizes cost-effective, quality API manufacturing with a robust regulatory environment.

  • Gujarat Fluorochemicals Ltd.
    Engaged in fluoride chemical manufacturing; supplies pharmaceutical-grade sodium fluoride and related APIs. Their facilities are compliant with USFDA and other international standards.

  • SRF Limited
    Offers fluoride-based APIs with GMP certification, serving both domestic and export markets.

3. Multinational Chemical & API Manufacturers

Several globally recognized companies serve as reliable sources of fluoride APIs, primarily for large pharmaceutical companies requiring consistent quality and regulatory approval.

  • Pfizer Inc. (USA)
    Known for internal API manufacturing capabilities for fluoride compounds, particularly for proprietary dental care products, with supply chains aligned with strict quality standards.

  • BASF SE (Germany)
    Produces fluoride chemicals suitable for pharmaceutical applications, emphasizing high purity and formulation scalability.

  • Sinopharm Chemical Reagents Beijing Co., Ltd. (China)
    Provides a range of fluoride APIs with international certification, catering to global markets.

4. Contract Manufacturing Organizations (CMOs)

CMOs offer custom synthesis and scale-up services across regions, providing flexibility and regulatory compliance.

  • Novasep (France)
    Specializes in pharmaceutical intermediate APIs, including fluoride-based compounds, with validated GMP processes.

  • LTS Lohmann Therapie-Systeme AG (Germany)
    Offers contract synthesis for fluoride APIs with focus on high purity and stability requirements.

  • WuXi AppTec (China)
    Provides integrated API manufacturing services, including fluoride API synthesis and scale-up for global clients.


Regional Dynamics and Supply Chain Considerations

  • Asia-Pacific: Dominant in fluoride chemical production, with China and India leading. Cost advantages are significant; however, regulatory harmonization remains vital for global distribution.

  • North America and Europe: Focus on high regulatory compliance, GMP-certified manufacturing, and supply chain transparency. Suppliers like BASF and Pfizer serve these markets predominantly.

  • Emerging Markets: Countries like Mexico, Brazil, and South Africa are expanding fluoride API manufacturing capacity, often leveraging regional trade agreements and domestic demand.


Emerging Trends and Future Outlook

  • Regulatory Harmonization: Increasing standardization via ICH guidelines promotes global sourcing, pushing suppliers to adopt strict quality systems.

  • Vertical Integration: Major pharmaceutical firms are incentivizing internal API production or exclusive sourcing agreements to ensure supply security.

  • Environmental and Sustainability Concerns: Green chemistry innovations are pushing suppliers toward greener synthesis processes, influencing future sourcing paradigms.

  • Supply Chain Resilience: Recent disruptions underscore the importance of diversified supplier bases, regional partnerships, and inventory management.


Conclusion

Securing a reliable, high-quality bulk API source for Fluonid requires strategic alignment with suppliers that meet stringent regulatory standards, offer consistent supply, and align with cost objectives. Emerging regional manufacturers, especially in China and India, provide cost-effective options, while multinational corporations and CMOs prioritize quality assurance and regulatory compliance.

A diversified sourcing strategy, combining regional suppliers with global leaders, ensures resilience and mitigates supply chain risks. Continuous monitoring of regulatory developments and industry innovations further positions companies to maintain reliable Fluonid API supply.


Key Takeaways

  • The primary global sources of Fluonid API are located in China, India, and Europe, with a growing presence in North America.
  • Cost, quality, and regulatory compliance remain central to selection; manufacturers must prioritize GMP standards.
  • Regional manufacturing hubs offer cost advantages but require due diligence concerning quality and regulatory track record.
  • Establishing diversified supplier relationships enhances supply chain resilience amid geopolitical and logistical challenges.
  • Innovations in sustainable chemistry and regulatory harmonization are influencing future API sourcing strategies.

FAQs

1. What are the primary chemical forms of Fluonid used as APIs?
Common fluoride APIs include sodium fluoride, stannous fluoride, and ammonium fluoride, each used in dental health formulations depending on formulation requirements.

2. How does regulatory compliance influence API sourcing for Fluonid?
Regulatory standards like GMP, USP, and EP dictate supplier qualification. Suppliers must demonstrate adherence through certifications, audit compliance, and consistent quality to be considered reliable.

3. Are Chinese manufacturers a trustworthy source of Fluonid APIs?
Yes, many Chinese manufacturers produce pharmaceutical-grade fluoride APIs meeting international standards. Due diligence involves verifying GMP certification, regulatory approvals, and audit histories.

4. What factors should companies consider when choosing a Fluonid API supplier?
Key factors include product purity, regulatory compliance, manufacturing capacity, lead times, cost, and supplier reputation.

5. How might future trends affect the sourcing landscape for Fluonid APIs?
Sustainable synthesis methods, global regulatory harmonization, and supply chain diversification will shape future sourcing, emphasizing quality, transparency, and resilience.


[1] World Health Organization. "Fluoride and Dental Caries," 2019.
[2] U.S. Pharmacopeia. "USP Monograph on Sodium Fluoride," 2022.
[3] European Pharmacopoeia. "Fluoride API Standards," 2021.
[4] Market reports on global fluoride chemicals and APIs, 2022.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.